Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapy

2003 | Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Dana F Chace, Ron L DeBlanc, R Patrick Gearing, Tim D Bovee, Clay B Siegall, Joseph A Francisco, Alan F Wahl, Damon L Meyer & Peter D Senter
Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapy Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Dana F Chace, Ron L DeBlanc, R Patrick Gearing, Tim D Bovee, Clay B Siegall, Joseph A Francisco, Alan F Wahl, Damon L Meyer & Peter D Senter Nat. Biotechnol. 21, 778–784 (2003) In the legend to Figure 4d on page 781, cIgG Ag $ ^{-} $ should be cAC10 Ag $ ^{-} $ . Corrigendum: A model of molecular interactions on short oligonucleotide microarrays Li Zhang, Michael F Miles & Kenneth D Aldape Nat. Biotechnol. 21, 818–821 (2003) In the legend to Figure 1 on page 819, text in parts b and c was transposed. The legend should have read as follows: (b) Weight factors. (c) Nearest-neighbor stacking energy. These stacking energies weakly correlated $ (r = 0.6) $ with that found in aqueous solution $ ^{8} $ , and are smaller in magnitude. In the legend to Figure 2 on page 820, figure parts were referred to incorrectly. The legend should have read as follows: Accuracy test. Known concentrations of 14 $ ^{'} $ spike-in $ ^{'} $ genes are compared with those obtained from (a) PDNN, (b) MAS5.0 and (c) dChip. Each line represents a gene in 14 samples. The microarray raw data were obtained from the '1532 series' human data (see Methods for URL). For genes other than the 'spike-ins', standard deviations (s.d.) versus the averages of the log-transformed expression levels are shown in d, e and f as determined using PDNN, MAS5.0 and dChip $ ^{7} $ , respectively. Each of these figures contains 12,474 genes; top half shown in red.Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapy Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Dana F Chace, Ron L DeBlanc, R Patrick Gearing, Tim D Bovee, Clay B Siegall, Joseph A Francisco, Alan F Wahl, Damon L Meyer & Peter D Senter Nat. Biotechnol. 21, 778–784 (2003) In the legend to Figure 4d on page 781, cIgG Ag $ ^{-} $ should be cAC10 Ag $ ^{-} $ . Corrigendum: A model of molecular interactions on short oligonucleotide microarrays Li Zhang, Michael F Miles & Kenneth D Aldape Nat. Biotechnol. 21, 818–821 (2003) In the legend to Figure 1 on page 819, text in parts b and c was transposed. The legend should have read as follows: (b) Weight factors. (c) Nearest-neighbor stacking energy. These stacking energies weakly correlated $ (r = 0.6) $ with that found in aqueous solution $ ^{8} $ , and are smaller in magnitude. In the legend to Figure 2 on page 820, figure parts were referred to incorrectly. The legend should have read as follows: Accuracy test. Known concentrations of 14 $ ^{'} $ spike-in $ ^{'} $ genes are compared with those obtained from (a) PDNN, (b) MAS5.0 and (c) dChip. Each line represents a gene in 14 samples. The microarray raw data were obtained from the '1532 series' human data (see Methods for URL). For genes other than the 'spike-ins', standard deviations (s.d.) versus the averages of the log-transformed expression levels are shown in d, e and f as determined using PDNN, MAS5.0 and dChip $ ^{7} $ , respectively. Each of these figures contains 12,474 genes; top half shown in red.
Reach us at info@study.space